361 Capital’s Elevance Health ELV Stock Holding History

361 Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,646	Closed	-$1.12M	–	340
2019 Q3	$1.12M	Sell	4,646 -54	-1%	-$14.8K	0.21%	197
2019 Q2	$1.33M	Buy	4,700 +215	+5%	+$58.7K	0.24%	192
2019 Q1	$1.29M	Buy	4,485 +2,780	+163%	+$804K	0.22%	187
2018 Q4	$448K	Buy	+1,705	New	+$469K	0.09%	275

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

361 Capital's ELV Position: Q4 2019 in Review

361 Capital sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 4,646 shares — an estimated $1.12M sold.

361 Capital first reported a position in ELV in Q4 2018 and held it in 4 quarters. The position peaked at $1.33M in Q2 2019. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

361 Capital reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
361 Capital sold 4,646 Elevance Health shares in Q4 2019, an estimated $1.12M.
361 Capital first reported a position in Elevance Health in Q4 2018 and held it in 4 quarters.
361 Capital's Elevance Health position peaked at $1.33M in Q2 2019.
1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on 361 Capital's 13F filing for Q4 2019, filed 13 Feb 2020.